v3.24.1.u1
STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (7,380,793) $ (2,458,589)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of debt discount 188,119 140,430
 Issuance cost from shares issued on extension of bridge loan 201,600
 Stock-based compensation 1,733,233 110,146
 Shares issued for license 2,225,733
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses 1,627,005 413,603
Accrued compensation 424,072 221,875
Due to parent 5,386
Net Cash Used In Operating Activities (981,031) (1,567,149)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from loan payable, net of debt discount 201,008
Proceeds from loan payable - related party, net of debt discount 565,928 100,000
Proceeds from bridge loan, net of debt discount 300,000
Shares issued for cash 255,412
Net contribution from Chromocell Corporation 422,173
Advance from Chromocell Corporation 800,050
Net Cash Provided By Financing Activities 1,022,348 1,622,223
NET INCREASE (DECREASE) IN CASH 41,317 55,074
CASH AT BEGINNING OF PERIOD 55,074
CASH AT END OF PERIOD 96,391 55,074
Supplemental cash flow information:    
Cash paid for income taxes
Cash paid for interest expense
NONCASH INVESTING AND FINANCING ACTIVITIES:    
Fair value of shares issued in contribution agreement 1,900,000
Debt discount from shares issued on extension of bridge loan 428,400
Shares forfeited $ 13

Source

HTML PDF
ZIP